Inner nuclear layer(INL) microcysts at central macula are a common finding in patients with epiretinal membrane (ERM) after vitrectomy and membrane peeling. Using en face mode of optical coherence tomography (OCT) angiography, patients with ERM after surgery were retrospectively reviewed to understand the configuration and distribution of microcysts as well as their impact on visual acuity. Forty-six eligible patients were enrolled and their baseline best-corrected visual acuities improved from 20/67 to 20/29 (P < 0.01) after surgery. Twenty-eight (60.9%) patients had microcysts that appeared at a median of 5 months after the surgery and persisted for mean 16 months follow-up. The microcyst appeared as spheroidal shape with length ranged from 20 to 80 μm and widths of 80 μm in average. They tend to group in cluster with a density of 245 microcysts per mm2. The frequency of microcyst distribution was 86%, 54%, 32%, 25% and 18% at the nasal, superior, inferior, temporal quadrants and central 1 mm, respectively. Linear regression analysis showed that INL microcysts at central and temporal quadrants were associated with poorer visual acuity (P = 0.02 and P = 0.01, respectively). The presence of INL microcysts in center subfield and involved wider area is a poor prognostic factor for visual outcomes.
Vitrectomy and peeling of the epiretinal membrane (ERM) have been a safe, effective, and widely used treatment strategy for idiopathic ERM1. However, some reports have revealed that surgery can cause inner retinal damage, including swelling of the arcuate nerve fiber layer2, dissociated optic nerve fiber layer defect3, secondary paracentral macular hole4, and microcysts in the inner nuclear layer (INL) of the retina5.
Studies have reported that the incidence of postoperative INL microcysts is approximately 1–29%5,6. The microcysts occurred in patients who presented with more acute symptom onsets, more severe grades of ERM with paravascular anomalies, and intraoperative petechiae after ERM peeling5. The INL microcysts appeared as early as 1 month after the surgery, and they may persist for more than 12 months. Although patients with postoperative INL microcysts had improved visual acuity after surgery, the visual gain was less compared with patients without the postoperative microcysts.
Although INL microcysts can be observed with cross-sectional optical coherence tomography (OCT), their distribution, area, and impact on visual prognosis are still unknown. The split-spectrum amplitude-decorrelation angiography OCT with motion correction introduced in 2012 can provide images not only of blood vasculature, but also enhanced 3-dimensional retinal structures by increasing scanning speeds and reducing motion artifacts. The goal of this study was to analyze the characteristics and functional outcomes of INL microcysts after double membrane peeling in patients with ERM using the newer en-face mode OCT.
INL microcysts and visual outcome
Forty-six eligible participants (13 males; 33 females; mean age = 64.0 ± 7.2) were enrolled. Their baseline BCVA improved from 20/67 (LogMAR 0.60 ± 0.27) to 20/29 (LogMAR 0.23 ± 0.28) (P < 0.01) after surgery with a mean follow-up of 16.3 ± 6.5 months. Twenty-eight (60.9%) patients had INL microcysts that appeared at a median of 5 months (1–16 months) after the surgery and persisted during the follow-up period. The distribution of the appearance time of INL microcysts was highly left skewed, with 32% of the patients having microcysts found 3 months after the surgery.
Compared with the nonmicrocystic group, there was a trend of worse preoperative visual acuity and thicker preoperative central macular thickness in the microcystic group. However, there were still no significant differences between postoperative visual acuity and central macular thickness between patients with or without microcysts (Table 1). Furthermore, the duration of symptoms before the operation and the follow-up period after the surgery were not significantly different between the two groups.
Morphology and distribution of INL microcysts
We measured the vertical distance of INL microcyst from top to down as the length in B-scan of the OCT, and the maximum distance from side to side as the width in cross-sectional OCT image. The length of the individual INL microcysts ranged from 20 to 80 μm, and the width ranged from 60 to 120 μm, with 80 μm in average. We also measured the maximum diameter of the microcysts in the en face view, and found that it ranged from 32 to 192 μm, with 72 μm in average. This is because that the composite of multiple A scan lines in the en face mode could pick up smaller circular microcysts than the cross sectional scans. These observations suggest that the INL microcyst is actually a spheroid space that has been vertically distorted into a spindle shape in the conventional reporting of commercial OCT because of uncoordinated horizontal and vertical scales (Fig. 1). The microcysts generally grouped together in a clustered honeycomb pattern with many clustering near the paramacular area. For each microcyst cluster, the density was approximately 245 microcysts per mm2 (Fig. 1).
In the subfield analysis in Table 2, 86% of the patients who had microcysts had microcysts involving the nasal subfield. Other involved subfields with microcysts were 18% at the center 1 mm in diameter, and 54%, 32%, and 25% at the superior, inferior, and temporal quadrants, respectively. Regarding the numbers of involved areas, 11 patients had INL microcysts in only one subfield; 7, 6, and 4 patients had microcysts in 2; and 3 had microcysts in more than 3 subfields, respectively. Among the 11 patients who had microcysts in 1 subfield, 8 had microcysts only at the nasal field, whereas 3 developed them at the center subfield. For those 10 patients who had at least 3 or more subfields affected, all involved the nasal and superior subfields, 8 involved the inferior subfield, 6 involved the temporal subfield, and only 1 involved the center subfield.
Patients who had a final visual acuity of less than 20/29 had larger areas of INL microcysts that covered temporal, inferior, and central areas in addition to the nasal subfield (Fig. 2).
Factors associated with visual outcome
Linear regression analysis showed that, among patients with microcysts, those who had worse final visual acuities had microcysts at the central and temporal quadrants (P = 0.02, P = 0.01, respectively) (Table 3). Numbers of affected subfields of 4 or more were associated with worse visual acuity (P < 0.01) compared with those who had less than 3 subfields affected.
Layer thickness analysis
For retinal layer thickness analysis (Fig. 3), the INL thickness with microcysts (51 ± 16 μm) was thicker than those without microcysts (48 ± 11 μm, P < 0.001). However, the total retinal thickness with microcysts (388 ± 44 um) was thinner than those without microcysts (414 ± 29 μm, P < 0.001) because of a thinner outer retinal layer in those with microcysts (145 ± 27 vs 168 ± 25 μm, P < 0.001).
In this study, by using OCT angiographic mode for en-face imaging, we found that INL microcysts are a common retinal change in patients with ERM after double membrane peeling. Sixty-one percent of patients developed INL microcysts during the follow-up period. This rate was more frequent than in our previous study of 29% that were imaged with only two cross-sectional OCT scans and at a lower resolution. Compared with other studies with even lower incidences, in addition to the more severe preoperative features of our patients, such as poorer presenting visual acuity, thicker macula, or longer follow-up period5, the image tools and methods to detect the microcysts were key.
The OCT angiography used 70 000 A-scans per second with an axial resolution of 5 μm and a transverse resolution of 15 μm7. A macular examination which contains 180 000 A-scans for an area of 3 × 3 mm could be finished in less than 3 seconds to minimize motion artifacts and acquire higher quality of image. Using a novel angiography algorithm, an application was developed to investigate many small inner retinal lesions and minor changes, such as those in the inner retinal capillary plexus, foveal avascular zone, and peripapillary capillary8,9. However, this system still has a considerable advantage even with only the tomography from split-spectrum amplitude-decorrelation angiography algorithms10,11. The en face of the tomography, generated from more than 200 B-scans in 3 mm, could ideally provide a 15-μm transverse resolution to evaluate INL microcysts.
The finer resolution OCT used in our study not only showed higher prevalence of microcysts as compared with our previous study, the risk factors and visual outcomes identified also differed from those of the last study. More acute symptoms before surgery, more severe grades of ERM, and intraoperative retinal hemorrhage were no longer the associated factors for postoperative microcysts as observed in this study5. Furthermore, the presence of microcysts was not associated with poorer visual outcomes as previously observed. In the previous study, the microcysts were underestimated and their locations were mainly at the center 1 mm and nasal side by 2 cross-sectional OCT. However, wider areas of more than 4 subfields and involvement of center and temporal subfields in this study were still associated with acute symptoms of less than 6 months and poorer functional recovery. This implied that microcysts are a common phenomenon after ERM surgery and that more severe forms of microcysts, such as a wider involved area, are a prognostic factor for worse visual recovery.
Most of the patients had INL microcysts in their nasal subfields. In patients who had microcysts distributed in less than 2 subfields, 10 of 14 (71%) had microcysts in the nasal area, whereas in patients with larger microcystic areas that extended to more than 2 subfields, all had microcysts in the nasal area. The reason why the nasal subfield was affected more than other subfields is unknown.
In patients with optic atrophy, the INL microcysts were also dominantly located at the papillomacular bundle area12. The authors proposed that the cell volume loss in the ganglion cell layer and thinning of the nerve fiber layer make the INL expand vertically to compensate for the space created by the vitreous traction, hence the formation of microcysts. Although there was no optic atrophy in our patients and the vitreous was already removed, it was possible that after surgery, the decrease of the ganglion cell layer with the still-stretched and expanded INL might leave space for compensated microcyst formation13. The thickness analysis in the nasal subfield (as shown in Fig. 3) confirmed that in regions of microcysts, the INL thickness increased more than those without microcysts. According to this hypothesis, the microcysts should become less when the whole retinal layer thickness decreased following the surgery, yet the microcysts persisted for long as shown in this 16-month study. The other possible mechanism is actual cell loss but without compensated spacing.
Compared with macular holes, Akira Hirata et al. found that specimens of peeled ILM after ERM surgery had larger and higher numbers of cell fragments on the retinal side, indicating higher risk of inner retinal damage14. However, it was unknown if there were topographic changes to the peeled ILM such that more fragments were found in the nasal side of the ILM (personal discussion with Dr. Akira Hirata). Sigler et al. claimed that the INL microcysts had a delayed onset and were the likely result of Müller cell depletion through various intracellular mechanisms after physical trauma15. This retrograde trans-synaptic hypothesis was possible and may be secondary to inner retinal loss after ILM peeling. However, it was unknown if the Müller cells distributed differently at the macula so that there were more densely packed Müller cells at the papillomacular bundle, and hence, more cell loss in the nasal subfield. The preponderance of microcysts in the nasal subfield remains speculative.
Our thickness layer analysis in Fig. 3 shows that the INL thickness in areas with microcysts was higher than in patients without microcysts. This might indicate a poorer functional recovery, because the middle retinal layer thickness is negatively correlated with b wave and oscillatory potential amplitude after ERM surgery16. However, the full thickness layer in areas with microcysts was thinner than areas without microcysts. This was because of a thinner outer retinal layer underneath the microcysts but not the inner retinal layer thickness above the INL, which was comparable between the 2 (Fig. 3). In an animal model, conditional selectively impaired Müller cells may induce outer nuclear layer cell death and photoreceptor apoptosis and yet a relatively preserved inner retina17. The microcysts in the INL layer might indicate Müller cell damage that leads to outer retinal layer loss. This observation requires further validation.
Notably, subclinical cystoid macular edema and Irvine–Gass syndrome can mimic INL microcysts. Some topical agents that may cause macular edema should be used with caution. In the present study, most of the eyes observed (38 of 46) had undergone phacoemulsification during the follow-up period. Only 1 patient had cystoid macular edema, which was resolved after Sub-Tenon’s injection of triamcinolone, although the microcysts from before the cataract surgery persisted after the cystoid edema resolved. No significant change of the microcysts occurred in our longitudinal observation of the patients in the microcystic group. Fluorescein angiography was performed for a suspicious patient, and no dye pooling was found, indicating that the post-vitrectomy microcysts were not related to inflammation or vascular leakage.
This study had some limitations, which included that as a retrospective study, some of the patients might not have had regular OCT evaluations, especially at the early postoperative period. Second, the artifacts of en-face OCT may still obscure the detection of microcysts, especially when the microcysts were small or sparse. In such cases, manual segmentation of OCT images was performed to search the microcysts and eliminate the error during autosegmentation. Third, dividing the macula into five ETDRS areas is a new strategy that has not been validated in ERM studies. We thought that dividing the areas into nasal, intermediate (superior, inferior, and central), and temporal spaces sequentially was a reasonable approach because of the anatomy of the retinal nerve fiber layer.
High-speed scanning OCT could provide acceptable imaging quality to evaluate INL microcysts, which were rarely found using conventional OCT in patients with idiopathic ERM after double membrane peeling. The microcysts appeared as clusters of densely packed spheroidal cystic defects of 80 um in diameter and mostly located at nasal subfield. Although patients with microcysts attained a final visual acuity of greater than 20/28, patients with microcysts at the central and temporal areas and with wider involved areas of greater than 4 subfields had poorer outcomes.
We retrospectively reviewed the medical records of patients who had idiopathic ERM and underwent surgery from March 2015 to February 2016. Exclusion criteria included the presence of other retinal disease, secondary ERM, glaucoma, and optic atrophy. Postoperative patients who had transient INL cystic edema following cataract surgery were not enrolled as having INL microcysts. Patients with insufficient OCT images or a follow-up period of less than 12 months were excluded. All the participant have signed and agreed the relevant inform consent. This study was approved by the institutional review board and ethics committees of Taipei Veteran General Hospital in Taiwan. We also confirmed that all research was performed in accordance with the relevant guidelines and regulations.
All patients underwent pars plana vitrectomy and double membrane peeling performed by the same surgeon (SJ Chen). The brilliant blue G-assisted membrane peeling was performed as previously described in detail for all cases5. All internal limiting membrane at the macular area was peeled, and the initiation site was always selected outside the macula. At the end of the surgery, fluid gas exchange with air was performed, and all patients were instructed to remain in a prone position for 2 days.
All patients underwent comprehensive ophthalmic examination, including best-corrected visual acuity (BCVA), fundus color photographs, and OCT. The OCT was performed by a trained technician with a commercial OCT scanner, the Avanti RTVue XR (OptoVue, Fremont, CA, USA). The “Angio” mode was used, which contains more than 180 000 A-scans in a 3 × 3 mm image volume. The microcysts in the INL were defined by groups of spindle-shaped hyporeflective hollows within the layer in the cross-sectional OCT and appeared as multiple continuous adjacent dark spots by the “en face” of the deep capillary plexus (Fig. 1). The microcysts were revealed after manual adjustment for proper segmentation if needed.
We divided the center 3 × 3 mm into 5 subfields, the superior, nasal, inferior, temporal, and center, for further analysis (Fig. 1).
Multivariate linear regression analysis was used to evaluate the association between the presence of INL microcysts and visual outcome in each area, adjusted by age and preoperative visual acuity. The area of each INL microcyst cluster was drawn manually in each eye (Fig. 1B, irregular circle) and all areas were added on to be presented as a distribution and frequency map after transformation to the left eye configuration by mirror image. To understand the thickness changes in the retinal layers in the nasal subfield of microcysts, 9 patients with microcysts, 3 patients without microcysts, and 4 age-matched normal controls with good image quality were enrolled for comparison. The clustering microcysts were randomly sampled with a maximum of 120 points for each patient. In those patients without microcysts, the sampling consisted of 120 points evenly distributed in the nasal subfield. The thickness of each segmentation of each retinal layer was measured with Orion OCT analysis software (Voxeleron, Pleasanton, CA, USA) that could semi-automatically perform image segmentation and calculate the thickness of the region of interest. The statistic was calculated using analysis of variance, and Scheffe post hoc analysis was performed among the three groups. Regarding the large number of samples P = 0.001 was considered as the level of significance.
Ghazi-Nouri, S. M., Tranos, P. G., Rubin, G. S., Adams, Z. C. & Charteris, D. G. Visual function and quality of life following vitrectomy and epiretinal membrane peel surgery. The British journal of ophthalmology 90, 559–562 (2006).
Clark, A. et al. Swelling of the arcuate nerve fiber layer after internal limiting membrane peeling. Retina (Philadelphia, Pa.) 32, 1608–1613 (2012).
Tadayoni, R. et al. Dissociated optic nerve fiber layer appearance of the fundus after idiopathic epiretinal membrane removal. Ophthalmology 108, 2279–2283 (2001).
Steven, P., Laqua, H., Wong, D. & Hoerauf, H. Secondary paracentral retinal holes following internal limiting membrane removal. The British journal of ophthalmology 90, 293–295 (2006).
Chen, S. J., Tsai, F. Y., Liu, H. C., Chung, Y. C. & Lin, T. C. Postoperative Inner Nuclear Layer Microcysts Affecting Long-Term Visual Outcomes After Epiretinal Membrane Surgery. Retina (Philadelphia, Pa.) 36, 2377–2383 (2016).
Sigler, E. J., Randolph, J. C. & Charles, S. Delayed onset inner nuclear layer cystic changes following internal limiting membrane removal for epimacular membrane. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 251, 1679–1685 (2013).
Huang, D., Jia, Y., Gao, S. S., Lumbroso, B. & Rispoli, M. Optical Coherence Tomography Angiography Using the Optovue Device. Developments in ophthalmology 56, 6–12 (2016).
Gao, S. S. et al. Compensation for Reflectance Variation in Vessel Density Quantification by Optical Coherence Tomography Angiography. Investigative ophthalmology & visual science 57, 4485–4492 (2016).
Spaide, R. F., Klancnik, J. M. Jr. & Cooney, M. J. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA ophthalmology 133, 45–50 (2015).
Gao, S. S., Liu, G., Huang, D. & Jia, Y. Optimization of the split-spectrum amplitude-decorrelation angiography algorithm on a spectral optical coherence tomography system. Optics letters 40, 2305–2308 (2015).
Jia, Y. et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Optics express 20, 4710–4725 (2012).
Jiramongkolchai, K., Bhatti, M. T., Proia, A., Freedman, S. F. & El-Dairi, M. A. Formation of Macular Inner Nuclear Layer Cysts in Optic Atrophy. Investigative ophthalmology & visual science 57, 989–991 (2016).
Lee, E. K. & Yu, H. G. Ganglion cell-inner plexiform layer thickness after epiretinal membrane surgery: a spectral-domain optical coherence tomography study. Ophthalmology 121, 1579–1587 (2014).
Hirata, A., Murata, K., Hayashi, K. & Nakamura, K. I. Three-Dimensional Analysis of Peeled Internal Limiting Membrane Using Focused Ion Beam/Scanning Electron Microscopy. Translational Vision Science &. Technology 7, 15 (2018).
Sigler, E. J. Microcysts in the inner nuclear layer, a nonspecific SD-OCT sign of cystoid macular edema. Investigative ophthalmology & visual science 55, 3282–3284 (2014).
Hibi, N. et al. Relationship between retinal layer thickness and focal macular electroretinogram components after epiretinal membrane surgery. Investigative ophthalmology & visual science 54, 7207–7214 (2013).
Shen, W. et al. Conditional Mullercell ablation causes independent neuronal and vascular pathologies in a novel transgenic model. The Journal of neuroscience: the official journal of the Society for Neuroscience 32, 15715–15727 (2012).
The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Hsieh, M., Chou, Y., Huang, Y. et al. Inner Nuclear Layer Microcyst Configuration, Distribution, and Visual Prognosis in Patients With Epiretinal Membrane After Vitrectomy and Membrane Peeling. Sci Rep 9, 11570 (2019) doi:10.1038/s41598-019-48097-1